Skip to content

Clinical trials

Phase 4 Obesity trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 4 Country / region: China Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20111
20132
20141
20151
20161
20173
20192
20211
20221
20234
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status9
Not yet recruiting5
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School3
China National Center for Cardiovascular Diseases2
Guangzhou General Hospital of Guangzhou Military Command2
RenJi Hospital2
Third Military Medical University2
Xiang Guang-da2
Affiliated Hospital of Nantong University1
Changhai Hospital1
Huazhong University of Science and Technology1
Jing Liu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity27
Overweight10
Diabetes Mellitus, Type 24
Polycystic Ovary Syndrome4
Hypertension3
Obesity, Abdominal3
Non-alcoholic Fatty Liver Disease2
Weight Loss2
Atrial Fibrillation1
Body Weight1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.